Announcements Trials
Browse Landscape

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Breast 1

Conditions

Triple Negative Breast Neoplasms 1Neoplasm Metastasis 1Breast Neoplasms 1

Interventions

Gemcitabine 74Paclitaxel 60Capecitabine 60Fluorouracil 58Oxaliplatin 57Docetaxel 51Bevacizumab 51Leucovorin 48Nivolumab 41Irinotecan 40Cisplatin 40Carboplatin 37Cetuximab 34Radiosurgery 33pembrolizumab 32Trastuzumab 30Radiotherapy 27Everolimus 24Sorafenib 23Albumin-Bound Paclitaxel 21Pemetrexed 20Doxorubicin 20Ipilimumab 19Cyclophosphamide 19Panitumumab 18Zoledronic Acid 17Lapatinib 17Erlotinib Hydrochloride 17Prednisone 16pazopanib 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Neoplasm Metastasis × Biopsy, Large-Core Needle × Clear all
NCT01276899 2022-06-02

Study to Identify Molecular Mechanisms of Clinical Resistance to Chemotherapy in Triple Negative Breast Cancer Patients

Jewish General Hospital

Completed
80 enrolled
Breast

Breast Neoplasms, Neoplasm Metastasis, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡